- 51404-69-4Acetic acid, lead salt,basic
- 51407-20-6Cyclohexanol,2-methyl-5-(1-methylethyl)-, 1-acetate, (1R,2R,5S)-rel-
- 5140-72-7Pyridine,2-bromo-6-chloro-
- 514-07-827-Norolean-14-en-3-one, 13-methyl-, (13α)-
- 514-10-31-Phenanthrenecarboxylicacid, 1,2,3,4,4α,4β,5,6,10,10α-decahydro-1,4α-dimethyl-7-(1-methylethyl)-,(1R,4αR,4βR,10αR)-
- 51410-30-15H-Pyrido[3,2-a]phenoxazine-3-carboxylicacid, 1-hydroxy-5-oxo-, sodium salt (1:1)
- 51410-46-9Oxirane,2-(4-methoxyphenyl)-3-methyl-
- 51411-23-5D-Fructose, 1-O-a-D-glucopyranosyl-
- 51411-81-5Benzoic acid,3-amino-4-iodo-
- 51-41-21,2-Benzenediol,4-[(1R)-2-amino-1-hydroxyethyl]-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
l-Noradrenaline tartrate |
EINECS | 200-095-0 |
| CAS No. | 51-40-1 | Density | N/A |
| PSA | 201.77000 | LogP | -1.33240 |
| Solubility | N/A | Melting Point |
102-104 °C |
| Formula | C8H11NO3.C4H6O6 | Boiling Point | 442.6 °C at 760 mmHg |
| Molecular Weight | 319.268 | Flash Point | 221.5 °C |
| Transport Information | N/A | Appearance | White crystalline powder |
| Safety | Risk Codes | N/A | |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
l-Noradrenaline bitartrate;Levophed bitartrate;(-)-Noradrenaline acid tartrate;Benzyl alcohol, .alpha.- (aminomethyl)-3,4-dihydroxy-, (-)-, tartrate (1:1);(-)-Noradrenaline bitartrate;(-)-Norepinephrine bitartrate;Noradrenaline hydrogen tartrate;Noradrenaline tartrate;(-)-Norepinephrine (+)-bitartrate;Benzyl alcohol, .alpha.- (aminomethyl)-3,4-dihydroxy-, (-)-, tartrate (1:1) (salt);Noradrenaline bitartrate;1,2-Benzenediol, 4- (2-amino-1-hydroxyethyl)-, (R)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1) (salt);Noradrenaline acid tartrate;Arterenol bitartrate;Norepinephrine bitartrate;(-)-Norepinephrine tartrate;(-)-Noradrenaline bitartrate monohydrate;Noradrenaline, tartrate (1:1);(-)-Noradrenaline hydrogen tartrate;(-)-Noradrenaline tartrate;Norartrinal bitartrate;l-Noradrenaline d-bitartrate;l-Arterenol bitartrate;Levarterenol bitartrate;1,2-Benzenediol,4-[(1R)-2-amino-1-hydroxyethyl]-,(2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt);(-)-Noradrenaline (+)-bitartrate;4-(2-amino-1-hydroxy-ethyl)benzene-1,2-diol; 2,3-dihydroxybutanedioic acid;Norepinephrine tartrate; |
l-Noradrenaline tartrate Synthetic route
- 42028-44-4
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-undecan-1-al
- 51-40-1
norepinephrine bitartrate
| Conditions | Yield |
|---|---|
| With 2-picoline borane complex In isopropyl alcohol at 20℃; for 0.25h; |
l-Noradrenaline tartrate Specification
The l-Noradrenaline tartrate, with the CAS registry number 51-40-1 and EINECS registry number 200-095-0, has the systematic name of 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol 2,3-dihydroxybutanedioate (1:1). It belongs to the product categories: Standards - 13C & 2H for GC-Mass Spectrometry. And the molecular formula of the chemical is C8H11NO3.C4H6O6.
The characteristics of l-Noradrenaline tartrate are as followings: (1)ACD/LogP: -0.88; (2)# of Rule of 5 Violations: 1 ; (3)#H bond acceptors: 4; (4)#H bond donors: 5; (5)#Freely Rotating Bonds: 6; (6)Polar Surface Area: 30.93 Å2; (7)Flash Point: 221.5 °C; (8)Enthalpy of Vaporization: 73.79 kJ/mol; (9)Boiling Point: 442.6 °C at 760 mmHg; (10)Vapour Pressure: 1.3E-08 mmHg at 25°C.
Addtionally, the following datas could be converted into the molecular structure:
(1)SMILES: O=C(O)C(O)C(O)C(=O)O.Oc1ccc(cc1O)[C@@H](O)CN
(2)InChI: InChI=1/C8H11NO3.C4H6O6/c9-4-8(12)5-1-2-6(10)7(11)3-5;5-1(3(7)8)2(6)4(9)10/h1-3,8,10-12H,4,9H2;1-2,5-6H,(H,7,8)(H,9,10)/t8-;/m0./s1
(3)InChIKey: WNPNNLQNNJQYFA-QRPNPIFTBL
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 26800ug/kg (26.8mg/kg) | Dissertationes Pharmaceuticae et Pharmacologicae. Vol. 23, Pg. 435, 1971. | |
| mouse | LD50 | intravenous | 1025ug/kg (1.025mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES LUNGS, THORAX, OR RESPIRATION: DYSPNEA | European Journal of Pharmacology. Vol. 9, Pg. 289, 1970. |
| rat | LD50 | intravenous | 210ug/kg (0.21mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 7, Pg. 627, 1979. |
| rat | LDLo | subcutaneous | 3987ug/kg (3.987mg/kg) | BEHAVIORAL: EXCITEMENT | Journal of Pharmacology and Experimental Therapeutics. Vol. 95, Pg. 155, 1949. |
What can I do for you?
Get Best Price
